奥门丁-1通过Nrf2激活和氧化还原调节来改善实验性炎症性肠病
Meihui Tao1, Wei Yan2, Chaoyue Chen1
1Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
奥门-1,一种在炎症性肠病 (IBD) 中减少的蛋白质,通过激活Nrf2通路来保护肠道屏障. 这项研究揭示了Omentin-1作为IBD治疗的潜在治疗标.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 在患有炎症性肠病 (IBD) 的患者中,欧门丁-1水平降低.
- 在IBD病变发生过程中,奥门丁-1的确切作用和机制尚不完全理解.
- 研究奥门丁-1对于开发新的IBD疗法至关重要.
研究的目的:
- 调查IBD中的Omentin-1的表达和功能.
- 阐明奥门丁-1在IBD中发挥作用的潜在分子机制.
- 评估Omentin-1作为IBD的潜在治疗点.
主要方法:
- 从IBD患者和对照组收集人体血清和结肠活检样本.
- 使用硫酸德克斯 (DSS) 诱导的大肠炎和脂聚糖 (LPS) 诱导HT-29细胞的小鼠模型.
- 服用奥门丁-1和/或Nrf2抑制剂 (ML385) 来评估对炎症,肠道屏障功能,氧化应激和信号通路 (Nrf2,NF-κB) 的影响.
主要成果:
- 与健康对照人群相比,性结肠炎 (UC) 和克罗恩病 (CD) 患者的血清奥门丁-1水平显著降低.
- 奥门丁-1治疗改善了炎症,改善了肠道屏障功能,减少了氧化应激标志物 (ROS,MDA) 和增加了抗氧化剂标志物 (GSH,SOD) 在体内和体外.
- 奥门丁-1激活了Nrf2通路,从而改善了氧化还原平衡和抑制NF-κB信号传递,在奥门丁-1和Nrf2之间发现了直接相互作用.
结论:
- 奥门丁-1通过激活Nrf2通道来在IBD中发挥保护作用,该通道调节氧化还原平衡并增强肠道屏障功能.
- 这些发现突显了Omentin-1作为治疗剂的潜力,可以减少IBD的肠道炎症.
- 奥门丁-1代表了一种有前途的治疗点,用于管理炎症性肠病.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Regulation of the Unfolded Protein Response
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
